Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04698876
Other study ID # 01NVF18002
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 11, 2021
Est. completion date November 30, 2023

Study information

Verified date January 2024
Source University Hospital Muenster
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The SALUS project is developing a new form of care, the application of self-tonometry by the patient itself, and an accompanying electronic case file connecting clinics, doctor's offices and patients.


Description:

The SALUS project is developing an outpatient, intersectoral form of care in which patients measure their intraocular pressure in their home environment with a so-called self-tonometer. The measured intraocular pressure values are incorporated into daily pressure profiles, which can be viewed via an electronic case file together with further examination data both by the treating ophthalmologists in the doctor's offices and clinics and by the patients. The new form of care not only supports the telemedical networking of doctors but also increases the compliance by involving the patient in the entire course of the illness.


Recruitment information / eligibility

Status Completed
Enrollment 267
Est. completion date November 30, 2023
Est. primary completion date October 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Requirement of a stationary day and night measurement - Statutory health insurance - Verified and suspicion of glaucoma diagnosis with suspicion of pressure variations and peaks or not attained target pressure or suspicion of glaucoma progression (H40.1, H40.2 und H42.-) - Willingness for therapy in one of the participating clinics - Adequate German language skills - Signed and dated informed consent for study participation and data transfer - Legal capacity of the insurant to agree to the study participation Exclusion Criteria: - Patients outside the catchment area of the participating clinics - Covering illnesses in psychiatry, neurology or other indications (e.g. impairment of independence) which make self-tonometry impossible - Strong communication barriers that do not allow the instruction to carry out the intervention - Unclear legal capacity of the potential study participants

Study Design


Intervention

Procedure:
Self-tonometry by means of ICareHOME
Outpatient measurement of intraocular pressure at home
Intraocular measurement by means of rebound tonometry or Goldmann applanation tonometry
Stationary measurement of intraocular pressure in a clinic
Blood pressure
Blood pressure measurement for 24 h

Locations

Country Name City State
Germany Klinikum Dortmund Dortmund
Germany St.-Johannes-Hospital Dortmund Dortmund
Germany Kath. Krankenhaus Hagen, St.-Josefs-Hospital Hagen
Germany Klinikum Luedenscheid Lüdenscheid
Germany University Hospital Muenster Münster

Sponsors (9)

Lead Sponsor Collaborator
University Hospital Muenster AOK PLUS, BARMER, Bielefeld University, DAK Gesundheit, Federal Joint Committee, Fraunhofer Institute for Applied Information Technology FIT, IKK, KVWL

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of observed pressure peaks (>30% of the patient-specific target pressure) Measurement of intraocular pressure by means of ICareHOME, rebound tonometry or Goldmann applanation tonometry. 7 days (outpatient) or minimum 24 hours (stationary)
Secondary Quality of life (patient-oriented) By means of a questionnaire, 0: very bad state of health, 1: best possible state of health Baseline and after 12 months
Secondary Visual field index (VFI) By means of perimetry Baseline and after 9 and 12 months
Secondary Mean deviation (MD) By means of perimetry Baseline and after 9 and 12 months
Secondary Pattern standard deviation (PSD) By means of perimetry Baseline and after 9 and 12 months
Secondary Retinal nerve fiber layer thickness By means of Optical Coherence Tomography (OCT)/ Heidelberg Retina Tomography (HRT) Baseline and after 12 months
Secondary Rim volume By means of Optical Coherence Tomography (OCT)/ Heidelberg Retina Tomography (HRT) Baseline and after 12 months
Secondary Rim area By means of Optical Coherence Tomography (OCT)/ Heidelberg Retina Tomography (HRT) Baseline and after 12 months
Secondary Systolic and diastolic blood pressure Long-term blood pressure measurement for 24 hours during outpatient and stationary measurements of intraocular pressure
Secondary Number of inpatient and outpatient health services Care provider/ statutory health insurance (SHI) routine data 12 month course
Secondary Costs of health services Care provider/ SHI routine data 12 month course
Secondary Number of periods of incapacity for work (unspecific and diagnosis-specific) Interview/ SHI routine data 12 month course
Secondary Number of sick pay days Interview/ SHI routine data 12 month course
See also
  Status Clinical Trial Phase
Recruiting NCT06000865 - Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE N/A
Recruiting NCT06278597 - Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03274024 - The Asia Primary Tube Versus Trab (TVT) Study N/A
Completed NCT04552964 - Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma N/A
Recruiting NCT01957267 - Functional and Structural Imaging for Glaucoma
Active, not recruiting NCT04624698 - iStent Inject New Enrollment Post-Approval Study N/A
Completed NCT04020705 - The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma N/A
Completed NCT03150160 - Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma Phase 4
Not yet recruiting NCT05581498 - Glaucoma Exercise as Medicine Study (GEMS). N/A
Recruiting NCT02921568 - Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes N/A
Active, not recruiting NCT02901730 - Clinical Study of LPI With Different Laser Wavelengths N/A
Completed NCT02955849 - A Trial of China Laser and Surgery Study Glaucoma in Rural China Early Phase 1
Recruiting NCT02554214 - Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device N/A
Recruiting NCT02471105 - Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml Phase 4
Active, not recruiting NCT02390284 - Stop Retinal Ganglion Cell Dysfunction Study Phase 3
Completed NCT02628223 - 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma N/A
Completed NCT02246764 - Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Phase 3
Completed NCT02520674 - Glaucoma Screening With Smartphone Ophthalmology N/A
Completed NCT02653963 - Triamcinolone for Ahmed Glaucoma Valve N/A

External Links